Centene Corporation

Centene Corporation Earnings Recaps

CNC Health Care 3 recaps
Next earnings: February 5, 2027 (estimated) · full calendar
Q3 2026 Oct 28, 2026

Centene’s Q3 results and improved full-year outlook were broadly in line with the company’s stated business trends, while shares rose 1.0% after the earnings release. Medicare outperformed expectations, but Medicaid remains dependent on continued rate alignment as membership declines and eligibility changes progress.

Key takeaways
  • Adjusted EPS was $0.58, ahead of the company’s previous expectations; Centene raised its 2026 adjusted EPS outlook to greater than $5.20.
  • Medicaid HBR was 93.6%, improving 30 basis points sequentially; management said core trend was in line with expectations and maintained its full-year HBR trajectory of 93.5%.
  • Medicaid membership is expected to decline roughly 8% to 9% year over year by year-end 2026, with a further step-down in Q4; the company said related acuity impacts are reflected in guidance.
  • Medicare Advantage and standalone Part D exceeded expectations. Centene now expects Medicare to break even in 2026, a year earlier than previously expected.
  • Management held its full-year Medicaid composite rate view at about 5% and said it sees signs of better alignment with cost experience, while noting the January rate outlook remains early.
Q1 2026 Apr 30, 2026

Centene shares surged 24.1% following a significant first quarter outperformance, driven by upside in both adjusted EPS and margin improvement across core Medicaid and Medicare businesses. Management raised full-year 2026 adjusted EPS guidance above the prior target, citing operational execution and favorable medical trends.

Key takeaways
  • Q1 adjusted diluted EPS came in at $3.37, above previous expectations and providing the basis to raise the full-year 2026 adjusted EPS outlook to greater than $3.40 (versus prior >$3).
  • Medicaid operations outperformed on HBR, benefitting from lighter-than-forecast flu activity, weather-driven utilization tailwinds, and disciplined trend management actions.
  • Medicare segment (Medicare Advantage and PDP) delivered better-than-expected HBR of 84.9% and reported gains from improved membership mix and higher retention.
  • Commercial segment margins were in line with expectations; modest HBR pressure was offset by favorable SG&A.
  • Management reiterated a prudent outlook for the remainder of the year but sees continued opportunity for margin advancement and operational improvement.
Q3 2025 Oct 29, 2025

Centene Corporation reported strong third quarter 2025 results, with adjusted EPS of $0.50 exceeding expectations, driven by improved Medicaid performance and better-than-anticipated net investment income. The company raised its full-year adjusted EPS forecast to at least $2.

Key takeaways
  • Medicaid business saw a 150 basis point HBR improvement due to enhanced revenue from Florida and operational efficiencies.
  • Adjusted EPS guidance for 2025 increased from $1.75 to at least $2, reflecting strong performance across segments.
  • Strong Q3 net investment income exceeded prior forecasts, with potential adjustments anticipated in Q4.
  • SG&A costs showed favorable reductions, contributing to overall profitability despite market fluctuations.
  • Ongoing monitoring of marketplace utilization dynamics and Medicaid cost trends underscores focus on maintaining operational efficiency.